Governing stem cell science in China and India: emerging economies and the global politics of innovation
Governing stem cell science in China and India: emerging economies and the global politics of innovation
复制标题
治理中国和印度的干细胞科学：新兴经济体和全球创新政治
DOI：
10.1080/14636770802077090
复制
发表时间：
2008
影响因子：
1.8
通讯作者：
B. Salter
中科院分区：
文献类型：
--
作者：
B. Salter
干细胞科学是一个不稳定的政治领域。在重要的新卫生技术的科学和经济前景的推动下，干细胞科学已经在国际、区域和国家政策领域产生了政治化。中国和印度这两个新兴经济体担心失去一个重要的机会，正在推出旨在提高它们在这一领域的全球竞争地位的政策。鉴于中国和印度的科学、税收制度、监管、支持行业和金融市场所处的发展阶段与发达经济体不同，它们将自己独特的特点带入了干细胞全球化的流动政治。本文分析了他们在干细胞科学方面的创新方法，以及他们对全球政治竞争动态的独特贡献。
Stem cell science is a volatile political arena. Propelled by the scientific and economic promise of important new health technologies, stem cell science has produced politicisation across the international, regional and national policy domains. Concerned lest they should lose an important opportunity, the emerging economies of China and India are introducing policies designed to improve their global competitive position in this field. Given that their science, tax regimes, regulation, supporting industries and financial markets are at a different stage of evolution to that of the developed economies, China and India bring their own unique characteristics to the fluid politics of stem cell globalisation. This paper analyses their approaches to innovation in stem cell science and their distinctive contribution to the dynamics of the global political competition.